184 related articles for article (PubMed ID: 32238702)
1. Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases.
Fukuda R; Murakami T
Biol Pharm Bull; 2020; 43(4):596-607. PubMed ID: 32238702
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.
Varshosaz J; Vakilzadeh H; Ghassami E
Curr Pharm Des; 2016; 22(22):3466-85. PubMed ID: 26861646
[TBL] [Abstract][Full Text] [Related]
3. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.
Chaudhary J; Bower J; Corbin IR
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847457
[TBL] [Abstract][Full Text] [Related]
5. Ligand-coupled lipoprotein for ovarian cancer-specific drug delivery.
Corbin IR
Methods Mol Biol; 2013; 1049():467-80. PubMed ID: 23913238
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
7. [Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].
Xu Y; Jin XF; Ping QN; Liu HF; Chen M; Xu XM
Yao Xue Xue Bao; 2014 Jan; 49(1):23-9. PubMed ID: 24783501
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer nanoparticles for ocular drug delivery.
Kambhampati SP; Kannan RM
J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Zhang X; Huang G
Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
12. Ocular drug delivery.
Ghate D; Edelhauser HF
Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
14. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
15. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
[TBL] [Abstract][Full Text] [Related]
16. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
18. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
[TBL] [Abstract][Full Text] [Related]
20. [Drug delivery systems for the posterior segment of the eye: fundamental basis and applications].
Fialho SL; Cunha Júnior Ada S
Arq Bras Oftalmol; 2007; 70(1):173-9. PubMed ID: 17505743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
